このエントリーをはてなブックマークに追加
ID 30789
JaLCDOI
FullText URL
Author
Mihara, Koichiro
Miyazaki, Masahiro
Kondo, Tadashi
Fushimi, Kazuo
Tsuji, Toshiya
Inoue, Yusuke
Fukaya, Kenichi
Ishioka, Chikashi
Namba, Masayoshi
Abstract

We used a yeast functional assay (functional analysis of separated alleles in yeast: FASAY) to determine the p53 gene status of human cell lines maintained in our laboratory. This assay enables the researcher to score wild-type p53 expression on the basis of the ability of expressed p53 to transactivate the reporter gene HIS 3 via the p53-responsive GAL 1 promoter in Saccharomyces cerevisiae. The cell lines examined were ten hepatoma, two hepatoblastoma, three in vitro immortalized fibroblast, two osteosarcoma, a chondrosarcoma, an ovarian teratocarcinoma and a colon cancer cell line. Out of 20 cell lines, 11 cell lines had mutations in both alleles of the p53 gene, and another 8 cell lines had no mutation in the p53 gene. Thus, 55% of the cell lines examined had mutations in the p53. Interestingly, PA-1 cells had both the normal and the mutant p53 alleles, showing that FASAY is a useful method for detecting the wild-type and mutated p53 genes simultaneously. As for the three liver cell lines harboring HBsAg, there was no relationship between their p53 gene status and the presence of HBsAg. Two cell lines were normal for p53 status, while the other had a mutation of the p53 gene.

Keywords
p53 mutation
FASAY
cultured human cells
Amo Type
Article
Publication Title
Acta Medica Okayama
Published Date
1997-10
Volume
volume51
Issue
issue5
Publisher
Okayama University Medical School
Start Page
261
End Page
265
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
English
File Version
publisher
Refereed
True
PubMed ID
Web of Science KeyUT